Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles

By Yilmaz H   Ozgur K   Isikoglu M   Sonmez C   Uner M  

Gynecological Endocrinology, Vol. 19, Iss. 1, 2004-07 ,pp. : 40-46

Informa Healthcare

Access to resources Recommend Favorite

Combined treatment with biphosphonates, low-dose chemotherapy, and trastuzumab in receptor-negative breast cancer patients with bone marrow involvement

By Bezares S.   Amador M.L.   Castellano D.   Trigo J.M.   Cortes-Funes H.   Colomer R.  

European Journal of Internal Medicine, Vol. 12, Iss. 5, 2001-09 ,pp. : 462-463

Elsevier

Access to resources Recommend Favorite

Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women

By Ziller May   Herwig Julia   Ziller Volker   Kauka Annette   Kostev Karel   Hadji Peyman  

Gynecological Endocrinology, Vol. 28, Iss. 12, 2012-12 ,pp. : 1002-1005

Informa Healthcare

Access to resources Recommend Favorite

Bone calcium turnover, formation, and resorption in bromocriptine- and prolactin-treated lactating rats

By Lotinun Sutada   Limlomwongse Liangchai   Sirikulchayanonta Vorachai   Krishnamra Nateetip  

Endocrine Journal, Vol. 20, Iss. 1-2, 2003-02 ,pp. : 163-170

Humana Press, Inc

Access to resources Recommend Favorite